These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26808775)

  • 1. The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson's disease.
    Mustafa S; Martin HL; Burkly L; Costa A; Martins ML; Schwaninger M; Teismann P
    Neuroscience; 2016 Apr; 319():116-22. PubMed ID: 26808775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system.
    Echeverry R; Wu F; Haile WB; Wu J; Yepes M
    J Neuroinflammation; 2012 Mar; 9():45. PubMed ID: 22394384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization.
    Ameri H; Liu H; Liu R; Ha Y; Paulucci-Holthauzen AA; Hu S; Motamedi M; Godley BF; Tilton RG; Zhang W
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):801-13. PubMed ID: 24408972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 mediate cerebral ischemia-induced poly(ADP-ribose) polymerase-1 activation and neuronal death.
    Haile WB; Echeverry R; Wu F; Guzman J; An J; Wu J; Yepes M
    Neuroscience; 2010 Dec; 171(4):1256-64. PubMed ID: 20955770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor.
    Polek TC; Talpaz M; Darnay BG; Spivak-Kroizman T
    J Biol Chem; 2003 Aug; 278(34):32317-23. PubMed ID: 12794080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction between tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 promotes the recruitment of neutrophils into the ischemic brain.
    Haile WB; Echeverry R; Wu J; Yepes M
    J Cereb Blood Flow Metab; 2010 Jun; 30(6):1147-56. PubMed ID: 20068578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TWEAK/Fn14 signaling is required for liver regeneration after partial hepatectomy in mice.
    Karaca G; Swiderska-Syn M; Xie G; Syn WK; Krüger L; Machado MV; Garman K; Choi SS; Michelotti GA; Burkly LC; Ochoa B; Diehl AM
    PLoS One; 2014; 9(1):e83987. PubMed ID: 24416188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of fibroblast growth factor-inducible 14 (Fn14) expression levels via ligand-independent lysosomal degradation.
    Gurunathan S; Winkles JA; Ghosh S; Hayden MS
    J Biol Chem; 2014 May; 289(19):12976-88. PubMed ID: 24652288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways.
    Wang A; Zhang F; Xu H; Xu M; Cao Y; Wang C; Xu Y; Su M; Zhang M; Zhuge Y
    Mol Immunol; 2017 Jul; 87():67-75. PubMed ID: 28411440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GVHD.
    Chopra M; Brandl A; Siegmund D; Mottok A; Schäfer V; Biehl M; Kraus S; Bäuerlein CA; Ritz M; Mattenheimer K; Schwinn S; Seher A; Grabinger T; Einsele H; Rosenwald A; Brunner T; Beilhack A; Wajant H
    Blood; 2015 Jul; 126(4):437-44. PubMed ID: 26012567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of TWEAK with Fn14 leads to the progression of fibrotic liver disease by directly modulating hepatic stellate cell proliferation.
    Wilhelm A; Shepherd EL; Amatucci A; Munir M; Reynolds G; Humphreys E; Resheq Y; Adams DH; Hübscher S; Burkly LC; Weston CJ; Afford SC
    J Pathol; 2016 May; 239(1):109-21. PubMed ID: 26924336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-like weak inducer of apoptosis or Fn14 deficiency reduce elastase perfusion-induced aortic abdominal aneurysm in mice.
    Tarín C; Fernández-Laso V; Sastre C; Madrigal-Matute J; Gómez M; Zaragoza C; Egido J; Burkly LC; Martín-Ventura JL; Blanco-Colio LM
    J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25092786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade.
    van Kuijk AW; Wijbrandts CA; Vinkenoog M; Zheng TS; Reedquist KA; Tak PP
    Ann Rheum Dis; 2010 Jan; 69(1):301-4. PubMed ID: 19147618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of binding of tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) to fibroblast growth factor inducible 14 (Fn14).
    Fick A; Lang I; Schäfer V; Seher A; Trebing J; Weisenberger D; Wajant H
    J Biol Chem; 2012 Jan; 287(1):484-495. PubMed ID: 22081603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus.
    Zhao Z; Burkly LC; Campbell S; Schwartz N; Molano A; Choudhury A; Eisenberg RA; Michaelson JS; Putterman C
    J Immunol; 2007 Dec; 179(11):7949-58. PubMed ID: 18025243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fn14-Fc suppresses germinal center formation and pathogenic B cells in a lupus mouse model via inhibition of the TWEAK/Fn14 Pathway.
    Min HK; Kim SM; Park JS; Byun JK; Lee J; Kwok SK; Park YW; Cho ML; Park SH
    J Transl Med; 2016 Apr; 14():98. PubMed ID: 27098560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
    Tran NL; McDonough WS; Savitch BA; Sawyer TF; Winkles JA; Berens ME
    J Biol Chem; 2005 Feb; 280(5):3483-92. PubMed ID: 15611130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A further TWEAK to multiple sclerosis pathophysiology.
    Nazeri A; Heydarpour P; Sadaghiani S; Sahraian MA; Burkly LC; Bar-Or A
    Mol Neurobiol; 2014 Feb; 49(1):78-87. PubMed ID: 23873135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional expression of TWEAK and the receptor Fn14 in human malignant ovarian tumors: possible implication for ovarian tumor intervention.
    Gu L; Dai L; Cao C; Zhu J; Ding C; Xu HB; Qiu L; Di W
    PLoS One; 2013; 8(3):e57436. PubMed ID: 23469193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TWEAK-Fn14 system as a potential drug target.
    Wajant H
    Br J Pharmacol; 2013 Oct; 170(4):748-64. PubMed ID: 23957828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.